This article was originally published in The Gray Sheet
Will establish a direct sales force of between five and 15 representatives in Japan, the firm's largest market outside the U.S., by the end of the year. Scimed announced on July 30 that it "terminated its distributor agreement" with Japan Lifeline, who under a transition agreement negotiated between the two firms will supply Scimed with marketing information such as customer lists.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.